Croatia’s PharmaS to Make Generic Drugs in Serbia, Novosti Says
PharmaS d.o.o., a Croatian pharmaceutical company, plans an 11 million-euro ($14.6 million) plant in northeastern Serbia, Vecernje Novosti newspaper reported, citing an unidentified person at PharmaS’ Serbian unit.
The plant in Zrenjanin will open by mid-2012, producing generic cardiovascular and gastrointestinal medications, according to the report.
To contact the reporter on this story: Misha Savic in Belgrade at firstname.lastname@example.org
To contact the editor responsible for this story: James M. Gomez at email@example.com
Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.